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Table S1. Distribution of unadjusted and specific gravity (SG)-adjusted paternal urinary phenol concentrations (ng/ml). 
Concentration All cycles Cycle 1 Cycle 2 Cycle 3 
In vitro fertilization (IVF)     
Bisphenol A     
   Number of cycles 211 152 40 19 
   Unadjusted geometric mean 1.6 (0.8 – 2.8) 1.9 (0.7 – 3.1) 1.3 (0.8 – 2.5) 1.2 (0.6 – 2.0) 
   SG-adjusted geometric mean 1.8 (1.1 – 2.5) 1.9 (1.1 – 2.7) 1.8 (1.1 – 2.4) 1.7 (1.0 – 2.1) 
   SG-adjusted concurrent measure 1.8 (1.1 – 2.7) 1.8 (1.0 – 2.8) 1.6 (1.1 – 2.5) 2.2 (1.5 – 2.9) 
<LODa—n (%) 30 (14.2) 22 (14.5) 5 (12.5) 3 (15.8) 
Methyl paraben     
   Number of cycles 199 143 38 18 
   Unadjusted geometric mean 26.1 (10.3 – 87.5) 24.9 (9.5 – 105.0) 30.7 (11.4 – 81.9) 29.0 (10.3 – 70.6) 
   SG-adjusted geometric mean 29.3 (10.7 – 108.6) 29.3 (8.9 – 108.6) 31.4 (13.3 – 122.0) 27.7 (16.2 – 94.1) 
   SG-adjusted concurrent measure 28.5 (8.3 – 122.3) 27.8 (8.1 – 122.3) 34.4 (14.4 – 101.7) 35.2 (7.3 – 139.4) 
<LODa—n (%) 2 (1.0) 1 (0.7) 1 (2.6) 0 (0.0) 
Propyl paraben     
   Number of cycles 199 143 38 18 
   Unadjusted geometric mean 3.4 (0.8 – 15.1) 3.1 (0.8 – 16.0) 4.1 (0.8 – 12.4) 3.3 (1.0 – 8.9) 
   SG-adjusted geometric mean 3.5 (1.0 – 13.9) 3.3 (0.8 – 13.9) 4.9 (1.0 – 19.6) 2.8 (1.5 – 12.9) 
   SG-adjusted concurrent measure 3.3 (0.7 – 20.2) 2.9 (0.7 – 20.2) 7.4 (0.7 – 47.4) 1.9 (0.7 – 9.6) 
<LODa—n (%) 23 (11.6) 18 (12.6) 3 (7.9) 2 (11.1) 
Butyl paraben     
   Number of cycles 199 143 38 18 
   Unadjusted geometric mean 0.2 (0.2 – 0.7) 0.2 (0.2 – 0.7) 0.2 (0.2 – 0.8) 0.2 (0.2 – 0.5) 
   SG-adjusted geometric mean 0.4 (0.2 – 1.0) 0.3 (0.2 – 1.0) 0.4 (0.2 – 0.9) 0.3 (0.2 – 0.5) 
   SG-adjusted concurrent measure 0.3 (0.2 – 0.8) 0.4 (0.2 – 0.9) 0.4 (0.1 – 0.7) 0.2 (0.2 – 0.6) 
<LODa—n (%) 119 (59.8) 82 (57.3) 25 (65.8) 12 (66.7) 
Intrauterine insemination (IUI)     
Bisphenol A     
   Number of cycles 195 102 66 27 
   Unadjusted geometric mean 2.0 (1.0 – 3.6) 1.8 (0.9 – 3.6) 2.1 (1.0 – 3.3) 1.8 (1.0 – 3.9) 
   SG-adjusted geometric mean 1.9 (1.2 – 3.0) 2.0 (1.0 – 3.0) 1.9 (1.2 – 3.1) 1.5 (1.3 – 2.9) 
   SG-adjusted concurrent measure 1.8 (1.1 – 3.0) 2.0 (1.0 – 3.0) 2.1 (1.3 – 3.2) 1.6 (1.0 – 2.4) 
<LODa—n (%) 18 (9.2) 11 (10.8) 5 (7.6) 2 (7.4) 
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Concentration All cycles Cycle 1 Cycle 2 Cycle 3 
Methyl paraben     
   Number of cycles 182 96 62 25 
   Unadjusted geometric mean 24.9 (9.3 – 85.6) 22.7 (8.2 – 84.8) 26.9 (10.0 – 101.9) 24.4 (13.3 – 92.9) 
   SG-adjusted geometric mean 25.5 (10.9 – 78.2) 21.8 (9.4 – 80.0) 29.1 (11.5 – 80.8) 32.5 (13.8 – 61.7) 
   SG-adjusted concurrent measure 23.1 (9.4 – 78.3) 21.8 (9.4 – 80.0) 20.2 (9.4 – 73.3) 31.2 (9.6 – 145.4) 
<LODa—n (%) 2 (1.1) 2 (2.1) 0 (0.0) 0 (0.0) 
Propyl paraben     
   Number of cycles 182 96 62 25 
   Unadjusted geometric mean 2.7 (0.9 – 11.3) 2.4 (0.9 – 9.7) 3.3 (0.9 – 11.6) 3.2 (1.6 – 15.0) 
   SG-adjusted geometric mean 2.7 (0.9 – 15.5) 2.6 (0.9 – 12.2) 3.9 (0.9 – 11.4) 2.9 (1.3 – 19.0) 
   SG-adjusted concurrent measure 2.7 (0.8 – 19.4) 2.6 (0.9 – 12.2) 2.8 (0.7 – 21.6) 8.5 (0.8 – 26.7) 
<LODa—n (%) 17 (9.3) 9 (9.4) 5 (8.1) 3 (12.5) 
Butyl paraben     
   Number of cycles 182 96 62 25 
   Unadjusted geometric mean 0.2 (0.2 – 0.3) 0.2 (0.2 – 0.3) 0.2 (0.2 – 0.4) 0.2 (0.2 – 0.7) 
   SG-adjusted geometric mean 0.2 (0.2 – 0.6) 0.2 (0.2 – 0.5) 0.2 (0.2 – 0.5) 0.3 (0.2 – 0.6) 
   SG-adjusted concurrent measure 0.2 (0.2 – 0.6) 0.2 (0.2 – 0.5) 0.2 (0.2 – 0.6) 0.2 (0.1 – 0.5) 
<LODa—n (%) 122 (66.7) 64 (66.7) 42 (67.7) 16 (66.7) 
Data are presented as median and interquartile range of the geometric mean of all urinary phenol measurements up to and including the cycle of 
interest; IVF, in vitro fertilization; LOD, limit of detection; IUI, intrauterine insemination 
aThe LOD for bisphenol A was 0.36-0.40 ng/ml, the LOD for methyl paraben was 1.0 ng/ml, and the LODs for propyl and butyl paraben were 0.2 
ng/ml
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Table S2. Associations between fertilization rate among initiated cycles and quartiles of 
geometric means of specific gravity-adjusted urinary phenol concentrations among men whose 
female partner underwent in vitro fertilization. 
Phenol quartiles  





RR (95% CI) 
Confounder-adjusteda 
aRR (95% CI) 
Bisphenol A 211   
   1 (≤1.05) 53 1.00 1.00 
   2 (1.06 – 1.81) 53 1.37 (0.91, 2.06) 1.37 (0.90, 2.06) 
   3 (1.82 – 2.52) 52 1.24 (0.82, 1.88) 1.24 (0.82, 1.89) 
   4 (2.53 – 22.91) 53 1.20 (0.79, 1.82) 1.20 (0.79, 1.82) 
   P-trendb  0.72 0.72 
Methyl paraben  199   
   1 (≤10.46) 51 1.00 1.00 
   2 (10.47 – 28.95) 48 1.18 (0.78, 1.79) 1.18 (0.77, 1.80) 
   3 (28.96 – 109) 51 1.46 (0.95, 2.25) 1.46 (0.95, 2.25) 
   4 (109 – 2,862) 49 0.99 (0.64, 1.54) 0.99 (0.64, 1.55) 
   P-trendb  0.51 0.52 
Propyl paraben  199   
   1 (≤0.99) 50 1.00 1.00 
   2 (1.00 – 3.47) 49 1.13 (0.74, 1.74) 1.13 (0.74, 1.75) 
   3 (3.48 – 13.93) 51 1.07 (0.70, 1.64) 1.07 (0.69, 1.64) 
   4 (13.94 – 842) 49 0.99 (0.64, 1.53) 0.99 (0.64, 1.53) 
   P-trendb  0.68 0.69 
Butyl paraben 199   
   Below the LODc 119 1.00 1.00 
   Above the LODc 80 1.00 (0.75, 1.34) 1.00 (0.75, 1.35) 
   Pd  0.97 0.98 
Fertilization rate was defined as the number of oocytes with two pronuclei divided by the number of 
mature metaphase II oocytes; IVF, in vitro fertilization; RR, rate ratio; CI, confidence interval; LOD, 
limit of detection. 
aAll models were adjusted for maternal age (years); no other confounders met the inclusion criteria for 
any model. bThe p-trend value was calculated using the median of each quartile as a continuous variable. 
cThe LOD for butyl paraben was 0.2 ng/ml. dThe p-value was calculated using above and below the LOD 
as categorical variables.  
No mediators met the inclusion criteria for any model, therefore we present a model adjusted for 
confounders only. 
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Table S3. Associations between the proportion of high-quality embryos among initiated cycles 
and quartiles of specific gravity-adjusted geometric mean urinary phenol concentrations among 
men whose female partner underwent in vitro fertilization. 
 
Phenol quartiles  





RR (95% CI) 
Confounder-adjusteda 
aRR (95% CI) 
Bisphenol A 211   
   1 (≤1.05) 53 1.00 1.00 
   2 (1.06–1.81) 53 1.91 (1.12, 3.25) 1.92 (1.13, 3.25) 
   3 (1.82–2.52) 52 1.31 (0.76, 2.28) 1.36 (0.79, 2.36) 
   4 (2.53–22.91) 53 1.24 (0.71, 2.15) 1.26 (0.73, 2.18) 
   P-trendb  0.80 0.85 
Methyl paraben  199   
   1 (≤10.46) 49 1.00 1.00 
   2 (10.47–28.95) 50 1.20 (0.70, 2.08) 1.14 (0.66, 1.98) 
   3 (28.96–109) 51 1.33 (0.76, 2.33) 1.34 (0.76, 2.34) 
   4 (109–2,862) 49 1.05 (0.58, 1.91) 1.08 (0.60, 1.95) 
   P-trendb  0.79 0.94 
Propyl paraben  199   
   1 (≤0.99) 51 1.00 1.00 
   2 (1.00–3.47) 48 1.14 (0.65, 2.01) 1.16 (0.66, 2.04) 
   3 (3.48–13.93) 51 0.75 (0.44, 1.32) 0.77 (0.44, 1.35) 
   4 (13.94–842) 49 0.99 (0.55, 1.79) 1.10 (0.61, 1.98) 
   P-trend  0.90 0.64 
Butyl paraben 199   
   Below the LODc 119 1.00 1.00 
   Above the LODc 80 1.22 (0.84, 1.78) 1.25 (0.85, 1.82) 
   Pd  0.29 0.25 
RR, rate ratio; aRR, adjusted rate ratio; CI, confidence interval; LOD, limit of detection. 
aAll models were adjusted for maternal age (years) and paternal normal weight (vs. overweight and 
obese); maternal normal weight (vs. overweight and obese) was additionally adjusted for in the models 
for bisphenol A and methyl and propyl paraben; maternal smoking (ever vs. never) was additionally 
adjusted for in the model for bisphenol A. bThe p-trend value was calculated using the median of each 
quartile as a continuous variable. cThe LOD for butyl paraben was 0.2 ng/ml. dThe p-value was calculated 
using above and below the LOD as categorical variables.  
No mediator met the inclusion criteria for any model, therefore we present a model adjusted for 
confounders only. 
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Table S4. Associations between implantation and quartiles of geometric means of specific 









OR (95% CI) 
Confounder-
adjusteda 
aOR (95% CI) 
Confounder-  and 
mediator-adjustedb 
aOR (95% CI) 
Bisphenol A 192    
   1 (≤1.05) 43 1.00 1.00 NAd 
   2 (1.06 – 1.81) 51 1.03 (0.41, 2.57) 1.05 (0.41, 2.69) NAd 
   3 (1.82 – 2.51) 49 1.02 (0.40, 2.61) 1.02 (0.39, 2.68) NAd 
   4 (2.52 – 22.91) 49 2.06 (0.77, 5.51) 2.37 (0.85, 6.61) NAd 
   P-trendc  0.11 0.07 NAd 
Methyl paraben  182    
   1 (≤10.46) 47 1.00 1.00  1.00 
   2 (10.47 – 29.38) 45 0.31 (0.12, 0.84) 0.42 (0.14, 1.26) 0.38 (0.13, 1.16) 
   3 (29.39 – 109) 44 0.72 (0.26, 1.98) 0.86 (0.29, 2.53) 0.86 (0.29, 2.54) 
   4 (109 – 2,862) 46 0.50 (0.18, 1.36) 0.55 (0.19, 1.61) 0.53 (0.18, 1.55) 
   P-trendc  0.70 0.59 0.57 
Propyl paraben  182    
   1 (≤0.99) 46 1.00 1.00 1.00 
   2 (1.00 – 3.47) 46 0.81 (0.30, 2.19) 1.02 (0.36, 2.87) 1.11 (0.37, 3.27) 
   3 (3.48 – 13.93) 44 0.63 (0.24, 1.62) 0.77 (0.28, 2.11) 0.76 (0.26, 2.17) 
   4 (13.94 – 842) 46 1.01 (0.37, 2.75) 0.95 (0.34, 2.67) 0.98 (0.33, 2.95) 
   P-trendc  0.62 0.98 0.95 
Butyl paraben 182    
   Below the LODe 112 1.00 1.00 1.00 
   Above the LODe 70 0.69 (0.35, 1.36) 0.75 (0.36, 1.57) 0.67 (0.31, 1.42) 
   Pf  0.28 0.44 0.29 
OR, odds ratio; aOR, adjusted odds ratio; CI, confidence interval; LOD, limit of detection. 
aAll models are adjusted for maternal age (years) and overall cycle number; paternal age (years) was 
additionally adjusted for in the models for methyl and butyl paraben; maternal smoking (ever vs. never) 
was additionally adjusted for in the models for methyl, propyl, and butyl paraben.  bAll models were 
adjusted for all variables listed above; any diagnosis of male factor infertility (yes vs. no) was additionally 
adjusted for in the models for propyl paraben; stimulation protocol (luteal phase vs. flare/antagonist) and 
the use of ICSI (yes vs. no) were additionally adjusted for in the models for methyl, propyl, and butyl 
paraben. cThe p-trend value was calculated using the median of each quartile as a continuous variable. 
dNo mediator met the inclusion criteria for any model, therefore we present a model adjusted for 
confounders only. eThe LOD for butyl paraben was 0.2 ng/ml. fThe p-value was calculated using above 
and below the LOD as categorical variables. 
